002755 Beijing Aosaikang Pharmaceutical
- 13.74
- +0.22+1.63%
About Beijing Aosaikang Pharmaceutical Company
The company was founded in 2003 and originated from the Nanjing Haiguang Institute of Applied Chemistry, one of the earliest private drug research and development institutions in Jiangsu Province. In 2019, the company officially entered the capital market. The company is a pharmaceutical manufacturing enterprise driven by innovation and research. The company's drug treatment field has covered the four major fields of digestion, anti-tumor, anti-infection, and chronic diseases, and its business covers R&D, production and sales of raw materials and formulations. Main Products: Omeprazole Sodium for Injection, Dexlansoprazole for Injection, Rosatidine Acetate for Injection, Esomeprazole Magnesium Dry Enteric Suspension, Esomeprazole Sodium for Injection, Lansoprazole for Injection, Rabeprazole Sodium for Injection, Dextrozosin for Injection, Nedaplatin for Injection, Temozolomide for Injection, Temozolomide Capsules, Lentivanib Mesylate Capsules, Pipribacil Capsules Fenn tablets, decitabine for injection, docetaxel injection, pemetrexed disodium for injection, zoledronic acid concentrated solution for injection, palonosetron hydrochloride injection , tigecycline for injection, posaconazole injection, posaconazole enteric tablets, polymyxin E sodium mesylate for injection, voriconazole for injection, daptomycin for injection, and saxagliptin tablets. Corporate honors: “Advanced Quality and Safety Management Unit”, “National Excellent Construction Enterprise for Production Safety”, “National Petroleum Reserve Phase I Project Technology Promotion and Application Advanced Collective”, “National Petroleum Reserve Phase I Project Technology Promotion and Application Special Advanced Collective”, “National Engineering Survey and Geotechnical Industry Top 10 Independent Technology Innovation Enterprise Award”, “AAA Enterprise Credit Rating”, “Science and Technology Innovation Enterprise Award”, “National Advanced Unit for Engineering Construction Safety”, “Excellent Petrochemical Engineering Construction Enterprise”, “Excellent Petrochemical Engineering Construction Enterprise”, won the Nanjing Municipal Civilized Unit, Nanjing Harmonious Labor Relations Demonstration Enterprise Honorary titles such as Enterprise, Little Family of Advanced Workers in Jiangning District, Nanjing, and Worker Pioneer.
Company Profile
Company Executives
- Name
- Position
- Salary
- qingcai chen
- Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
- 1.89M
- suling zhou
- Directors
- --
- youyin xu
- Directors, Deputy General Manager, Strategy Committee Members
- 2.00M
- xiaowen wang
- Directors
- 670.00K
- xiangfeng chen
- Directors, Strategy Committee Members, Audit Committee Members
- 1.00M
- jingfei ma
- Directors, Board Secretary, General Manager
- 900.00K
- jianwen liu
- Independent Directors, Chairman of the Nomination Committee, Audit Committee Members
- 100.00K
- xiaoming wu
- Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee
- 100.00K
- di li
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 100.00K
- yanyan wang
- Securities Affairs Representative
- --
- jing chen
- Chairman of the Supervisory Board, Auditors
- 800.00K
- tao han
- Chief Financial Officer
- 800.00K
- guigen zhang
- Head of Internal Audit
- --
- hongfang xue
- Employee Supervisors
- 300.00K
- yanrong zhao
- Employee Supervisors
- 400.00K
Analysis
Price Target
No Data
No Data